Logo image of AMPX

AMPRIUS TECHNOLOGIES INC (AMPX) Stock Fundamental Analysis

NYSE:AMPX - New York Stock Exchange, Inc. - US03214Q1085 - Common Stock - Currency: USD

2.42  -0.13 (-5.1%)

Premarket: 2.46 +0.04 (+1.65%)

Fundamental Rating

4

Taking everything into account, AMPX scores 4 out of 10 in our fundamental rating. AMPX was compared to 95 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for AMPX as it has an excellent financial health rating, but there are worries on the profitability. AMPX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMPX had negative earnings in the past year.
AMPX had a negative operating cash flow in the past year.
In the past 5 years AMPX always reported negative net income.
AMPX had a negative operating cash flow in each of the past 5 years.
AMPX Yearly Net Income VS EBIT VS OCF VS FCFAMPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

AMPX has a Return On Assets of -36.88%. This is in the lower half of the industry: AMPX underperforms 66.32% of its industry peers.
AMPX has a Return On Equity (-64.30%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -36.88%
ROE -64.3%
ROIC N/A
ROA(3y)-30.62%
ROA(5y)-51.34%
ROE(3y)-49.84%
ROE(5y)-171.03%
ROIC(3y)N/A
ROIC(5y)N/A
AMPX Yearly ROA, ROE, ROICAMPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

AMPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMPX Yearly Profit, Operating, Gross MarginsAMPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -100 -200 -300 -400

More info and screens

7

2. Health

2.1 Basic Checks

AMPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMPX has more shares outstanding
AMPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMPX Yearly Shares OutstandingAMPX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMPX Yearly Total Debt VS Total AssetsAMPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that AMPX is in the distress zone and has some risk of bankruptcy.
AMPX has a Altman-Z score (0.87) which is in line with its industry peers.
AMPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACCN/A
WACC9.12%
AMPX Yearly LT Debt VS Equity VS FCFAMPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 4.00 indicates that AMPX has no problem at all paying its short term obligations.
AMPX's Current ratio of 4.00 is amongst the best of the industry. AMPX outperforms 84.21% of its industry peers.
AMPX has a Quick Ratio of 3.61. This indicates that AMPX is financially healthy and has no problem in meeting its short term obligations.
AMPX has a Quick ratio of 3.61. This is amongst the best in the industry. AMPX outperforms 87.37% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.61
AMPX Yearly Current Assets VS Current LiabilitesAMPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

AMPX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.65%.
AMPX shows a strong growth in Revenue. In the last year, the Revenue has grown by 166.95%.
The Revenue has been growing by 105.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)166.95%
Revenue growth 3Y105.86%
Revenue growth 5YN/A
Sales Q2Q%383.05%

3.2 Future

AMPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.51% yearly.
AMPX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.14% yearly.
EPS Next Y27.36%
EPS Next 2Y37.26%
EPS Next 3Y22.49%
EPS Next 5Y21.51%
Revenue Next Year182.15%
Revenue Next 2Y202.5%
Revenue Next 3Y116.31%
Revenue Next 5Y101.14%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AMPX Yearly Revenue VS EstimatesAMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
AMPX Yearly EPS VS EstimatesAMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AMPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AMPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMPX Price Earnings VS Forward Price EarningsAMPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMPX Per share dataAMPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as AMPX's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.26%
EPS Next 3Y22.49%

More info and screens

0

5. Dividend

5.1 Amount

AMPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMPRIUS TECHNOLOGIES INC

NYSE:AMPX (5/21/2025, 8:04:00 PM)

Premarket: 2.46 +0.04 (+1.65%)

2.42

-0.13 (-5.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners20.88%
Inst Owner Change26.67%
Ins Owners10.25%
Ins Owner Change2.4%
Market Cap291.73M
Analysts81.54
Price Target9.69 (300.41%)
Short Float %5.86%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.5%
Min EPS beat(2)8.49%
Max EPS beat(2)20.51%
EPS beat(4)3
Avg EPS beat(4)3.81%
Min EPS beat(4)-20.57%
Max EPS beat(4)20.51%
EPS beat(8)6
Avg EPS beat(8)3.32%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)53.86%
Min Revenue beat(2)25%
Max Revenue beat(2)82.72%
Revenue beat(4)4
Avg Revenue beat(4)41.94%
Min Revenue beat(4)25%
Max Revenue beat(4)82.72%
Revenue beat(8)8
Avg Revenue beat(8)95.4%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.26%
PT rev (3m)12.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.69%
EPS NY rev (1m)13.65%
EPS NY rev (3m)20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)-2.52%
Revenue NY rev (3m)-4.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.07
P/FCF N/A
P/OCF N/A
P/B 4.2
P/tB 4.2
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.2
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.88%
ROE -64.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.62%
ROA(5y)-51.34%
ROE(3y)-49.84%
ROE(5y)-171.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.22%
Cap/Sales 13.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4
Quick Ratio 3.61
Altman-Z 0.87
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)384.03%
Cap/Depr(5y)247.44%
Cap/Sales(3y)80.23%
Cap/Sales(5y)54.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y27.36%
EPS Next 2Y37.26%
EPS Next 3Y22.49%
EPS Next 5Y21.51%
Revenue 1Y (TTM)166.95%
Revenue growth 3Y105.86%
Revenue growth 5YN/A
Sales Q2Q%383.05%
Revenue Next Year182.15%
Revenue Next 2Y202.5%
Revenue Next 3Y116.31%
Revenue Next 5Y101.14%
EBIT growth 1Y-14.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.63%
EBIT Next 3Y36.38%
EBIT Next 5Y40.63%
FCF growth 1Y15.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.52%
OCF growth 3YN/A
OCF growth 5YN/A